Jump to Main Contents
国立がん研究センター 中央病院

Home > Information

Information

Oct. 7, 2021
National Cancer Center Hospital on Newsweek’s “World’s Best Specialized Hospitals 2022 (Oncology)”
Sep. 13, 2021
Webinar on Clinical Research with Guangxi, China
Sep. 8, 2021
Shun-ichi Watanabe awarded the Ginsberg Lectureship Award for Surgery at the 2021 World Conference on Lung Cancer
Jun. 2, 2021
SARS-CoV-2 antibody status in patients with cancer during the COVID-19 pandemic in Japan
May 14, 2021
NATIONAL CANCER CENTER AND EISAI COMMENCE JOINT RESEARCH AND DEVELOPMENT PROJECT “BASIC RESEARCH ON THE DRUG DISCOVERY AND DEVELOPMENT TO ACCELERATE DEVELOPMENT OF ANTICANCER DRUGS IN TREATMENT OF PATIENTS WITH RARE CANCERS AND REFRACTORY CANCERS”, USING PDX WITH HIGH PREDICTABILITY OF CLINICAL OUTCOMES, AND CANCER GENOME DATA
Mar. 23, 2021
First drug approved for unresectable thymic carcinoma
Feb. 5, 2021
Endoscopy Lectures on the web
Nov. 19, 2020
MOU signed with Clinical Research Malaysia (CRM)
Oct. 19, 2020
National Cancer Center Hospital on Newsweek’s “World’s Best Specialized Hospitals 2021 (Oncology)”
Sep. 17, 2020
The Endoscopy Center Sharing Expertise Overseas
Sep. 9, 2020
Asian early phase drug development network
ATLAS Project – Paving the way towards developing drugs with Asian partners
Aug. 20, 2020
NCC joins GSK’s oncology development network
Mar. 2, 2020
HE Professor Tomasz Grodzki, Polish Senate Marshal visit
Feb. 21, 2020
To contain the spread of new coronavirus, the National Cancer Center of Japan requests your kind cooperation for the welfare of our patients
Jan. 29, 2020
Clinical Trial Investigators visit NCC Hospital
Dec. 11, 2019
Test Result of New Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting Proves Higher Efficacy Than Standard Antiemetic Therapy
Nov. 7, 2019
Commencement of Clinical Trial of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma and Angiosarcoma
Oct. 10, 2019
NCC colorectal Surgeons visit Sakha Republic, Russia
May 29, 2019
Cancer Gene Panel Test OncoGuideTM NCC Oncopanel System added to Health Insurance Coverage list
Mar. 7, 2019
Kazakhstan Delegation visit
Jan. 22, 2019
Dr Kazuaki Shimada appointed Honorary Professor at Tianjin Medical University Cancer Institute and Hospital
Nov. 19, 2018
Action across borders
Nov. 12, 2018
Facilitating International Clinical Trials Initiated by
Japanese Academic Institutions
Japan-led Global Investigator-Initiated Registration-Directed Trial of Advanced or Metastatic Breast Cancer (PATHWAY trial) Has Started
Apr. 3, 2018
National Cancer Center Hospital offers Next Generation Sequencing tests as ‘Advanced Medical Care’
Towards coverage under national health insurance system
Apr. 3, 2018
Advanced Medical Care Approval Received for Multiplex Gene Panel Testing
to Advancing Personalized Medicine
Feb. 5, 2018
Maestro Chung Visit
Aug. 1, 2017
On-Table Adaptive Radiation Therapy
Jul. 31, 2017
The MASTER KEY PROJECT
Genomic medicine in Rare Cancers:
A collaboration between the industry and academia